docetaxel anhydrous has been researched along with Thymus Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Liu, S; Ma, G; Song, W; Wang, H; Yu, G | 1 |
| Ahn, JS; Ahn, MJ; Ahn, Y; Chang, WJ; Choi, YS; Kim, H; Kim, J; Kim, K; Kwon, OJ; Lee, SJ; Park, K; Park, S; Shim, YM; Shin, S; Sun, JM | 1 |
| Goto, K; Kirita, K; Matsumoto, S; Niho, S; Ohmatsu, H; Umemura, S; Watanabe, N; Yoh, K | 1 |
| Becherer, A; De Vries, A; Drexel, H; Gasser, K; Gruber-Moesenbacher, U; Lang, A; Muendlein, A; Schuster, A; Winder, T | 1 |
| Achiwa, H; Kato, D; Maeda, H; Niimi, T; Oguri, T; Sato, S; Ueda, R | 1 |
| Hazama, K; Kagisaki, K; Matsuda, H; Miyoshi, S; Ohta, M; Shintani, Y | 1 |
1 review(s) available for docetaxel anhydrous and Thymus Neoplasms
| Article | Year |
|---|---|
Thymic carcinoma successfully resected with superior vena cava after chemoradiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Female; Humans; Middle Aged; Paclitaxel; Pericardial Effusion; Pleural Effusion, Malignant; Taxoids; Thymus Neoplasms; Vena Cava, Superior | 2001 |
1 trial(s) available for docetaxel anhydrous and Thymus Neoplasms
| Article | Year |
|---|---|
A prospective phase II trial of induction chemotherapy with docetaxel/cisplatin for Masaoka stage III/IV thymic epithelial tumors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Follow-Up Studies; Humans; Induction Chemotherapy; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Prognosis; Prospective Studies; Survival Rate; Taxoids; Thymus Neoplasms; Young Adult | 2013 |
4 other study(ies) available for docetaxel anhydrous and Thymus Neoplasms
| Article | Year |
|---|---|
Severe cardiotoxicity in 2 patients with thymoma receiving immune checkpoint inhibitor therapy: A case report.
Topics: Cardiotoxicity; Disease Progression; Docetaxel; Humans; Immune Checkpoint Inhibitors; Myocarditis; Thymoma; Thymus Neoplasms | 2022 |
Docetaxel for platinum-refractory advanced thymic carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Disease-Free Survival; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; Male; Middle Aged; Platinum Compounds; Retrospective Studies; Salvage Therapy; Taxoids; Thymoma; Thymus Neoplasms; Treatment Outcome | 2015 |
Advanced inoperable type B3 thymoma: monitoring of a novel therapeutic approach with radio-chemotherapy and sorafenib by FDG-PET and CT.
Topics: Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Doxorubicin; Epirubicin; Female; Humans; Image Processing, Computer-Assisted; Middle Aged; Paclitaxel; Radiation-Sensitizing Agents; Radiography; Radionuclide Imaging; Taxoids; Thymoma; Thymus Neoplasms; Treatment Outcome | 2010 |
Efficacy of docetaxel as a second-line chemotherapy for thymic carcinoma.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cervical Vertebrae; Docetaxel; Female; Humans; Mediastinal Neoplasms; Mediastinum; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy; Spinal Neoplasms; Taxoids; Thymoma; Thymus Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2004 |